Lupin receives UK advertising authorization for Luforbec

Lupin receives UK advertising authorization for Luforbec

by admin- Monday, June 14th, 2021 03:38:38 PM

Lupin introduced that its UK subsidiary, Lupin Healthcare (UK) Ltd has obtained approval from the Medicines and Healthcare merchandise Regulatory Agency (MHRA) to marketplace Luforbec a hundred/6 µg pressurized metered dose inhaler (pMDI), the first branded typical of Fostair100/6 µg pMDI, which has the ability to offer giant price financial savings for the NHS.

News Updates